Rare Hereditary Autoimmune Disease Found to Have More Common Form
By LabMedica International staff writers Posted on 21 Jun 2015 |

Image: Illustrated summary of the role of the AIRE gene product and its connection to a group of autoimmune disorders now discovered to be related. The AIRE gene is expressed in a rare population of the thymus, where it is critical for educating immune cells, called T cells, to discriminate between foreign invaders and body’s own proteins. Normally (top) AIRE operates in the form of a complex made up of four identical strands. When both copies of the AIRE gene are mutated (recessive), the resulting complex (middle) is dysfunctional and patients suffer from severe autoimmune disorders. When there are specific mutations in only one copy (dominant, bottom), the protein\'s function can still be disrupted and individuals can develop autoimmune disorders with different levels of severity. (Photo courtesy of Weizmann Institute of Science).

Image: Simplified view of AIRE protein functionality versus autoimmunity, depending on double- or single-allele AIRE gene mutations (Photo courtesy of Oftedal BE et al., June 2015, in Immunity).
Researchers have discovered that single-allele mutations in the gene that causes recessive autoimmune polyendocrine syndrome type-1 (APS-1) can cause a less severe but more common condition. Findings may help identify, diagnose, and treat a number of autoimmune diseases.
APS-1, caused by recessive (double-allele) mutation in the AIRE (AutoImmune REgulator) gene, is a constellation of medical problems ranging from attack on and destruction of multiple tissues and organs, to chronic infections. According to the new study, led by Dr. Jakub Abramson of the Weizmann Institute of Science (Rehovot, Israel) and Dr. Eystein S. Husebye of the University of Bergen (Bergen, Norway), APS-1 was thought to be exceedingly rare but now appears to have a less severe form that affects at least 1 in 1,000 people. Their results suggest that a number of autoimmune disorders may be linked to mutations in AIRE.
AIRE normally prevents such autoimmune attacks by overseeing the training of immune cells to ignore self-made antigens. AIRE is almost exclusively expressed in the thymus, where T-cells undergo a “basic training” before being released into the bloodstream for defense missions. In the thymus, AIRE operates in medullary thymic epithelial cells (mTECs), which act as “examiners,” checking that released T-cells will not react to self-antigens. mTECs create a comprehensive genomic expression library of self-antigens and test T-cells for their reactions—T-cells that attack a self-antigen are eliminated in the thymus. AIRE controls the expression of the thousands of self-antigen genes within the thymus. In another recent study (Nature Immunology), Dr. Abramson’s group discovered that AIRE is itself regulated by SIRT1, present at exceptionally high levels in mTECs and keeps AIRE activated.
Current medical wisdom assumes that clinical symptoms will arise only if both AIRE alleles are dysfunctional. Dr. Abramson and Dr. Husebye challenged this widely accepted notion and found that even a single-allele mutation may disrupt function and cause devastating autoimmunity. AIRE proteins bind one another, forming an active complex. A specific mutation in one copy is enough to disrupt function of the entire complex in a dominant-like manner.
The study arose from an unusual clinical observation in Dr. Husebye’s lab where a patient had an autoimmune syndrome suggesting recessive AIRE mutations, but was revealed to be mutated in only one allele. Among the patient’s children: those carrying the single-allele mutation had also developed an autoimmune disorder, but it was milder and did not match the symptoms of the recessive syndrome. Drs. Abramson and Husebye hypothesized that such dominant AIRE mutations may be a common cause of autoimmune disorders. The two research groups performed lab experiments and examined medical data from families in Norway, Finland, and Russia who suffered from various forms of autoimmunity. They found that many of those with single-allele AIRE mutations had been diagnosed with various autoimmune disorders.
“A dominant AIRE malfunction could explain the mechanism of a number of autoimmune diseases,” said Dr. Abramson. Further research revealed that only mutations at certain sites of the AIRE gene confer dominance over the healthy gene. Interestingly, however, the healthy gene is not completely negated: The dominant version of the disease is less severe, appears later in life, and may affect fewer organs than in APS-1.
The study, by Oftedal BE et al., was published June 16, 2015, in the journal Immunity.
Related Links:
Weizmann Institute of Science
University of Bergen
APS-1, caused by recessive (double-allele) mutation in the AIRE (AutoImmune REgulator) gene, is a constellation of medical problems ranging from attack on and destruction of multiple tissues and organs, to chronic infections. According to the new study, led by Dr. Jakub Abramson of the Weizmann Institute of Science (Rehovot, Israel) and Dr. Eystein S. Husebye of the University of Bergen (Bergen, Norway), APS-1 was thought to be exceedingly rare but now appears to have a less severe form that affects at least 1 in 1,000 people. Their results suggest that a number of autoimmune disorders may be linked to mutations in AIRE.
AIRE normally prevents such autoimmune attacks by overseeing the training of immune cells to ignore self-made antigens. AIRE is almost exclusively expressed in the thymus, where T-cells undergo a “basic training” before being released into the bloodstream for defense missions. In the thymus, AIRE operates in medullary thymic epithelial cells (mTECs), which act as “examiners,” checking that released T-cells will not react to self-antigens. mTECs create a comprehensive genomic expression library of self-antigens and test T-cells for their reactions—T-cells that attack a self-antigen are eliminated in the thymus. AIRE controls the expression of the thousands of self-antigen genes within the thymus. In another recent study (Nature Immunology), Dr. Abramson’s group discovered that AIRE is itself regulated by SIRT1, present at exceptionally high levels in mTECs and keeps AIRE activated.
Current medical wisdom assumes that clinical symptoms will arise only if both AIRE alleles are dysfunctional. Dr. Abramson and Dr. Husebye challenged this widely accepted notion and found that even a single-allele mutation may disrupt function and cause devastating autoimmunity. AIRE proteins bind one another, forming an active complex. A specific mutation in one copy is enough to disrupt function of the entire complex in a dominant-like manner.
The study arose from an unusual clinical observation in Dr. Husebye’s lab where a patient had an autoimmune syndrome suggesting recessive AIRE mutations, but was revealed to be mutated in only one allele. Among the patient’s children: those carrying the single-allele mutation had also developed an autoimmune disorder, but it was milder and did not match the symptoms of the recessive syndrome. Drs. Abramson and Husebye hypothesized that such dominant AIRE mutations may be a common cause of autoimmune disorders. The two research groups performed lab experiments and examined medical data from families in Norway, Finland, and Russia who suffered from various forms of autoimmunity. They found that many of those with single-allele AIRE mutations had been diagnosed with various autoimmune disorders.
“A dominant AIRE malfunction could explain the mechanism of a number of autoimmune diseases,” said Dr. Abramson. Further research revealed that only mutations at certain sites of the AIRE gene confer dominance over the healthy gene. Interestingly, however, the healthy gene is not completely negated: The dominant version of the disease is less severe, appears later in life, and may affect fewer organs than in APS-1.
The study, by Oftedal BE et al., was published June 16, 2015, in the journal Immunity.
Related Links:
Weizmann Institute of Science
University of Bergen
Latest Molecular Diagnostics News
- New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
- Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
- Revolutionary Blood Test Detects 30 Different Types of Cancers with 98% Accuracy
- Simple Blood Test Better Predicts Heart Disease Risk
- New Blood Test Detects 12 Common Cancers Before Symptoms Appear
- Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
- First-of-its-Kind Blood Test Detects Trauma-Related Diseases
- Key Gene Identified in Common Heart Disease Unlocks Life-Saving Diagnostic Potential
- Cheap Cell-Free DNA Based Test Accurately Predicts Preterm Birth
- RNA Blood Test Detects Cancers and Resistance to Treatment
- IL-6 Outperforms Traditional Tests for Early Sepsis Detection
- Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
- Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
- Novel Autoantibody Against DAGLA Discovered in Cerebellitis
- Blood Test Could Identify Patients at Risk for Severe Scleroderma
- Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more